Julie Brooks, PhD, is a Post-Doctoral Fellow within Pfizer’s Neuroscience Research Unit. Julie Brooks received her PhD from The Ohio State University where she examined how early developmental perturbations of the corticolimbic system alter the functional maturation of the cortex and contribute to cognitive deficits seen in schizophrenia.